Lab Members

Current team

Research Associates

Meiou Dai, Ph.D.

Meiou Dai, Ph.D.

meiou.dai@mail.mcgill.ca

Education : PhD in Experimental Medicine, University of McGill, Canada.

Current research : Genome-wide CRISPR/CAS9 loss-of-function screening for new cancer drug target discovery and biomarkers of drug resistance.

Ni Wang, Ph.D.

Ni Wang, Ph.D.

ni.wang79@gmail.com

  • Education : PhD.
  • Current research : My research focuses on pre-clinic experiments to investigate human cancerous processes and mechanisms by using immunodeficient laboratory mouse models (breast cancer, pancreas cancer, lung and liver metastases, etc.) in order to explore and develop novel therapies for cancer treatment.

Post-Doctorate Fellows

Jun Tian, Ph.D.

Jun Tian, Ph.D.

jun.tian3@mail.mcgill.ca

Education: Ph.D. in Experimental Medicine, McGill University

Current research: Investigation of the role of COX-2 and its associated genes in BCSC-mediated tumor metastasis and drug resistance.

Karine Pasturaud, Ph.D.

Karine Pasturaud, Ph.D.

karine.pasturaud@mail.mcgill.ca

  • Education : PhD in Organic Chemistry, University of Normandie, France.
  • Current research : Triple negative breast cancer is the most aggressive breast cancer subtype. While targeted therapies exist for the hormone receptor-positive breast cancer subtypes, there are no approved targeted treatments for TNBC. Following surgery, chemotherapy and radiotherapy remain the only options for treatment of TNBC. My project aims at developing novel potent CDK4 inhibitory compounds that can effectively target and eliminate CSCs likely to be therapeutically beneficial and may provide rationale for using a new type of targeted therapy in TNBCs patients

Graduate Students

Mostafa Ghozlan, Ph.D. candidate

Mostafa Ghozlan, Ph.D. candidate

mostafa.ghozlan@mail.mcgill.ca

  • Education : M.Sc. in Biochemistry and Molecular Biology, University of Calgary, Canada.
  • Current research : Investigating the TGF-beta mediated tumor suppressive effects in human cutaneous melanoma.
Sophie Poulet, Ph.D. Candidate

Sophie Poulet, Ph.D. Candidate

sophie.poulet@mail.mcgill.ca

  • Education : B.Sc. in Biopharmaceutical Sciences, Université de Montréal.
  • Current research : Evaluation of the therapeutic potential of a certain TGFb-mediated microRNA found to be upregulated in triple negative breast cancer. This is being tested in vitro as well as in vivo using CRISPR/Cas technology.
Julien Boudreault, Ph.D. Candidate

Julien Boudreault, Ph.D. Candidate

julien.boudreault@usherbrooke.ca

Education : M.Sc. in Molecular Biology at the University of Sherbrooke.

Current Research : The production of genetically modified cancer cell lines using the CRISPR technology and the cytotoxic study of kinase inhibitors in breast cancer.

Gang Yan, Ph.D. candidate

Gang Yan, Ph.D. candidate

gang.yan@mail.mcgill.ca

Education : B.Sc. in Biochemistry and Molecular Biology, Northeast Agricultural University, China.

Current research : Utilizing genome-wide Crispr/Cas9 screen based on paclitaxel to identify key genetic mutations responsible for paclitaxel resistance in triple negative breast cancer.

Haleema Al-Mesmary

Haleema Al-Mesmary

halmesmary@gmail.com

Education : Graduate degree in experimental surgery, McGill university, Montreal, Canada

High diploma in medical laboratories, High institute of medical technology, El-beyda, Libya.

Current research : TGF-beta1 mutation project, assessment of the effect of TGF-beta1 in the intensified bone formation and muscles disorder growth, translating current clinical data with the fundamental science in order to highlight its rule in a comprehensive manner, and deliver new therapeutic avenue.

Research Assistants

Girija Daliah

Girija Daliah

girija.daliah@muhc.mcgill.ca

Education : Diploma in Biotechnology, Algonquin College, Canada

Zahraa Qusairy

Zahraa Qusairy

qzahraa590@gmail.com

Education : MSc in Molecular Pathology and Toxicology, Leicester University, UK

Administration

Veronica Atehortua

Veronica Atehortua

veronica.atehortua@muhc.mcgill.ca

Program Assistant, Cancer Research Program (CRP)